On , Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug Administration (FDA) to initiate an ...

AI is already being used in clinics to help analyze imaging data, such as X-rays and scans. But the recent arrival of ...

A NEW study has demonstrated that AI can be used alongside mammography to effectively identify women at high risk of breast ...

Linkedin co-founder Reid Hoffman has launched a startup with the intention of using AI to fuel drug discovery. He is ...

Discover alarming trends and hopeful advances in cancer, predatory journals, and India's diagnostics sector in this insightful collection.

Lung cancer is a source of more cancer deaths in the U.S. than breast, colon and prostate cancer combined. People diagnosed ...

Discover how AI and machine learning predict breast cancer recurrence locations and metastasis, improving risk assessment and patient care.

Advertisers are leaning on nostalgia more than they used to in Super Bowl ads, according to Kimberly Whitler, a marketing professor at the University of Virginia’s Darden School of Business. Nods to ...

• Uber Eats and Instacart took similar tacks, brings out a multitude of products and characters all in the name of showing ...

The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.

The digital pathology software developer is raising funding that would help it to increase its headcount and support its Aiosyn Mitosis Breast application.

Duke University cancer researcher Prof Donald McDonnell on BTYSTE and how learning the scientific process at an early age is ...